Refine Search
(19)
(59)
(125)
(240)

Oncology

GlobalData provides unique and market-leading data and insights into the oncology market. Browse or search our Report Store for the latest comprehensive reports, market data, analysis and survey findings alongside industry information on key companies, markets and financial deals.

Brain Cancer Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Brain Cancer Global Clinical Trials Review, H2, 2018" provides an overview of Brain Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Brain Cance...

Brenner Tumor Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Brenner Tumor Global Clinical Trials Review, H2, 2018" provides an overview of Brenner Tumor clinical trials scenario. This report provides top line data relating to the clinical trials on Brenner T...

Burkitt Lymphoma Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Burkitt Lymphoma Global Clinical Trials Review, H2, 2018" provides an overview of Burkitt Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Bur...

Cancer Anorexia-Cachexia Syndrome Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Cancer Anorexia-Cachexia Syndrome Global Clinical Trials Review, H2, 2018" provides an overview of Cancer Anorexia-Cachexia Syndrome clinical trials scenario. This report provides top line data rela...

Cervical Cancer Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Cervical Cancer Global Clinical Trials Review, H2, 2018" provides an overview of Cervical Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Cervi...

Cholangiocellular Hepatoma Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Cholangiocellular Hepatoma Global Clinical Trials Review, H2, 2018" provides an overview of Cholangiocellular Hepatoma clinical trials scenario. This report provides top line data relating to the cl...

Chondrosarcoma Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Chondrosarcoma Global Clinical Trials Review, H2, 2018" provides an overview of Chondrosarcoma clinical trials scenario. This report provides top line data relating to the clinical trials on Chondro...

Chordoma Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Chordoma Global Clinical Trials Review, H2, 2018" provides an overview of Chordoma clinical trials scenario. This report provides top line data relating to the clinical trials on Chordoma. Report in...

Choriocarcinoma (Gestational Trophoblastic Neoplasia) Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Choriocarcinoma (Gestational Trophoblastic Neoplasia) Global Clinical Trials Review, H2, 2018" provides an overview of Choriocarcinoma (Gestational Trophoblastic Neoplasia) clinical trials scenario....

Hepatocellular Carcinoma: Competitive Landscape to 2026

  • $3,495
  • November 2018
Add to Basket Quick View Add to Saved List

Hepatocellular carcinoma (HCC) is the most common type of liver cancer. It is the sixth most common type of cancer, accounts for around 90% of primary liver cancers, and is third most common cause of cancer mortality. HCC is particularly aggres...

Chronic Lymphocytic Leukemia: Epidemiology Forecast to 2027

  • $3,995
  • November 2018
Add to Basket Quick View Add to Saved List

Chronic lymphocytic leukemia (CLL) (International Statistical Classification of Diseases and Related Health Problems, 10th Revision [ICD-10] code = C91.1), also known as chronic lymphoid leukemia, is a type of cancer of the white blood cells (l...

Chronic Lymphocytic Leukemia: Opportunity Analysis and Forecasts to 2027

  • $10,995
  • November 2018
Add to Basket Quick View Add to Saved List

Chronic lymphocytic leukemia (CLL) is a form of cancer that originates from lymphocytes in the bone marrow and later invades the blood and/or lymphoid tissues. CLL treatment has been transformed since the novel oral targeted agents Imbruvica (i...

Basal Cell Carcinoma (Basal Cell Epithelioma) Global Clinical Trials Review, H2, 2018

  • $2,500
  • November 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Basal Cell Carcinoma (Basal Cell Epithelioma) Global Clinical Trials Review, H2, 2018" provides an overview of Basal Cell Carcinoma (Basal Cell Epithelioma) clinical trials scenario. This report pro...

B-Cell Chronic Lymphocytic Leukemia Global Clinical Trials Review, H2, 2018

  • $2,500
  • November 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “B-Cell Chronic Lymphocytic Leukemia Global Clinical Trials Review, H2, 2018" provides an overview of B-Cell Chronic Lymphocytic Leukemia clinical trials scenario. This report provides top line data ...

B-Cell Leukemia Global Clinical Trials Review, H2, 2018

  • $2,500
  • November 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “B-Cell Leukemia Global Clinical Trials Review, H2, 2018" provides an overview of B-Cell Leukemia clinical trials scenario. This report provides top line data relating to the clinical trials on B-Cel...

Join our mailing list
Find out first about the latest reports and offers.